Peripheral Neuropathy Trial, Recruiting (NCT04867187)

Peripheral Neuropathy Trial, Recruiting NCT04867187 Sponsor: Centre Hospitalier Universitaire de Saint Etienne Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT04867187 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have symptoms that are typical of nerve pain (such as burning, shooting, or tingling pain)
Your pain has not been helped enough by medication
Your pain has been going on for at least 6 months, is rated 4 out of 10 or higher on a pain scale, and your pain treatment has stayed the same for at least the past month
You are covered by a health insurance or benefits scheme that entitles you to healthcare

Who may not be able to join:

You have any metal (magnetic) implants or implanted electronic devices in your body, such as cochlear implants (hearing implants)
You have epilepsy that cannot be controlled by medication, a pacemaker, are pregnant, are currently experiencing depression or personality disorders, or are currently taking opioid pain medicines
You have any other reason why you cannot have an MRI scan, such as claustrophobia (fear of enclosed spaces) or other implants (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roland Peyron, MDPHD, CENTRE HOSPITALIER DE SAINT-ETIENNE

Phone: (0)477825684

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04867187

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: (0)477825684

More information: https://clinicaltrials.gov/study/NCT04867187

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have symptoms that are typical of nerve pain (such as burning, shooting, or tingling pain)
Your pain has not been helped enough by medication
Your pain has been going on for at least 6 months, is rated 4 out of 10 or higher on a pain scale, and your pain treatment has stayed the same for at least the past month
You are covered by a health insurance or benefits scheme that entitles you to healthcare

Who may not be able to join:

You have any metal (magnetic) implants or implanted electronic devices in your body, such as cochlear implants (hearing implants)
You have epilepsy that cannot be controlled by medication, a pacemaker, are pregnant, are currently experiencing depression or personality disorders, or are currently taking opioid pain medicines
You have any other reason why you cannot have an MRI scan, such as claustrophobia (fear of enclosed spaces) or other implants (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Registry

ClinicalTrials.gov

Start date

27 October 2022

Est. completion

1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Pain intensity measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov